Clinomics Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 34.28 million compared to KRW 39.02 million a year ago. Net loss was KRW 10,177.01 million compared to net income of KRW 15,852.87 million a year ago.

Basic loss per share from continuing operations was KRW 768 compared to basic earnings per share from continuing operations of KRW 1,214 a year ago. Diluted loss per share from continuing operations was KRW 768 compared to diluted earnings per share from continuing operations of KRW 993 a year ago. Basic loss per share was KRW 768 compared to basic earnings per share of KRW 1,214 a year ago.